PRA Health Sciences said that a secondary offering by KKR PRA would be priced at $97.50 per share.

PRA holder KKR PRA Investors announced plans to offer 6.67 million shares in a press release Tuesday.

The Raleigh-based company said it intends to repurchase shares worth $300 million from the underwriter, Goldman Sachs & Co., simultaneously with the closing of the offering, set for September 6.

The company intends to fund the repurchase with the proceeds of a $300 million incremental term loan.

PRA Health Sciences is a contract research organization that offers product development and trial safety management.

The company’s shares were trading at $100.03 Wednesday, up $2.44.